Literature DB >> 20638430

Large double copy vectors are functional but show a size-dependent decline in transduction efficiency.

Tomas J Bos1, Elke De Bruyne, Sandra Van Lint, Carlo Heirman, Karin Vanderkerken.   

Abstract

The development of SIN-lentivectors has paved the way for the double copy vectors (DCV), which substitute the deletion in the 3'LTR with either transgenic or insulator sequences. However, the limits of this approach remain unclear. Previous results have demonstrated that transduction efficiencies of DCV carrying large insulator inserts in their 3'LTRs were impaired in a size-dependent manner. We wondered if this was also true for promoter-transgene inserts and whether they remained functional upon integration into the genome. Therefore, we designed a series of DCV with increasing 3'LTR sizes containing different promoter-transgene combinations. Transduced cells were scored for both transduction efficiency and insert functionality. We found that the transduction efficiencies indeed were impaired in a size-dependent way. Efficiency with inserts below 1 kb linearly decreased with size, while sizes between 1 and 2 kb showed a further decrease to a minimum of 5% of an original "empty" SIN-vector. However, we did not find an LTR size that completely abolished transduction. Moreover, we demonstrated that all inserts remained functional regardless the promoter-transgene combination used. Therefore, we conclude from our data that DCV indeed remain functional, but transduction efficiencies drop radically when inserts larger than 1 kb are being used.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638430     DOI: 10.1016/j.jbiotec.2010.07.010

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  14 in total

Review 1.  Navigating CAR-T cells through the solid-tumour microenvironment.

Authors:  Andrew J Hou; Laurence C Chen; Yvonne Y Chen
Journal:  Nat Rev Drug Discov       Date:  2021-05-10       Impact factor: 84.694

2.  T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells.

Authors:  Eugenia Zah; Meng-Yin Lin; Anne Silva-Benedict; Michael C Jensen; Yvonne Y Chen
Journal:  Cancer Immunol Res       Date:  2016-04-08       Impact factor: 11.151

Review 3.  The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.

Authors:  David W Emery
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

Review 4.  CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.

Authors:  ZeNan L Chang; Yvonne Y Chen
Journal:  Trends Mol Med       Date:  2017-04-13       Impact factor: 11.951

5.  Current progress and challenges in HIV gene therapy.

Authors:  Janet Chung; John J Rossi; Ulrike Jung
Journal:  Future Virol       Date:  2011-11-01       Impact factor: 1.831

Review 6.  CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies.

Authors:  Jian-Qing Mi; Jie Xu; Jianfeng Zhou; Weili Zhao; Zhu Chen; J Joseph Melenhorst; Saijuan Chen
Journal:  Front Med       Date:  2021-12-18       Impact factor: 4.592

7.  Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma.

Authors:  Eugenia Zah; Eunwoo Nam; Vinya Bhuvan; Uyen Tran; Brenda Y Ji; Stanley B Gosliner; Xiuli Wang; Christine E Brown; Yvonne Y Chen
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

Review 8.  The Application of Nanobody in CAR-T Therapy.

Authors:  Chaolemeng Bao; Quanli Gao; Lin-Lin Li; Lu Han; Bingxiang Zhang; Yijin Ding; Zongpei Song; Ruining Zhang; Jishuai Zhang; Xian-Hui Wu
Journal:  Biomolecules       Date:  2021-02-08

9.  Identification and characterization of enhancer-blocking insulators to reduce retroviral vector genotoxicity.

Authors:  Amy C Groth; Mingdong Liu; Hao Wang; Emilie Lovelett; David W Emery
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

10.  Nanobody Based Dual Specific CARs.

Authors:  Stijn De Munter; Joline Ingels; Glenn Goetgeluk; Sarah Bonte; Melissa Pille; Karin Weening; Tessa Kerre; Hinrich Abken; Bart Vandekerckhove
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.